Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum PsyBio Therapeutics Corp PSYBF

PsyBio Therapeutics Corp. is a Canada-based biotechnology company. The Company is focused on discovering, designing and developing psycho-focused therapeutics to improve mental and neurological conditions. It is focused on understanding the value of tryptamines and other related psycho-targeted molecules as therapeutic candidates to improve mental and neurological health. The Company is engaged... see more

GREY:PSYBF - Post Discussion

PsyBio Therapeutics Corp > Webinar and New Low For the Year?
View:
Post by Bookworm28 on May 13, 2021 1:54pm

Webinar and New Low For the Year?

I'm a bit confused. I listened to the CEO's webinar today. I thought it was pretty good, however, I see the stock is trading today at a new low for the year. What gives? 28 cents a share after the CEO's webinar?

PuerSimia, are you buying again?

How much overhang is there? This is frickin' brutal.
Comment by lonade on May 13, 2021 3:51pm
also perplexed... who's selling at these prices? the offering was at 0.35 cad and we have never been so low since trading started. so these sells are all at a loss...can't imagine shorts doing this. hold a bunch of shares and will sit this out;  will have to rebound at some stage
Comment by PuerSimia on May 13, 2021 11:03pm
Hey Bookworm. Tempting, but not buying at the moment. Not sure how to play it, as National just pounded it today. If they didn't kill it every time it tried to go up, we would have closed at .33+. I'd like to see them pound it down some more, then we'll see.
Comment by Bookworm28 on May 15, 2021 10:14pm
Sounds like a plan PuerSimia. I have to say, I am unimpressed with the 2 companies psyb is paying for market making and IR services. Lame volume and lame price. I'd turf 'em if things don't improve real soon. Evan is way to patient with these guys.
Comment by Bookworm28 on May 17, 2021 4:31pm
9,981 shares traded today. That's it? These guys really have to re-consider what value they are getting from their promotional/support people. I think grandma bookworm should join their team. She did mushrooms at woodstock. But seriously, what gives?
Comment by Bookworm28 on May 18, 2021 12:34pm
Another new low for the year this morning. It's time for management to evaluate what they're getting for their money. I can't believe they're OK with the results of the share price, given they're paying top dollar for a market maker and an IR firm to increase investor awareness. Judging by the number of posts on the this forum, and the Yahoo forum, I'd say there's a ...more  
Comment by ValueValue123 on May 18, 2021 1:35pm
I've done a deep dive on the company's information circulated dated February 2021 and their IP filings with the US Patent and Trademark Office. The science here is real with signficiant insider ownership. They've been listed on the OTC Pinks now for a couple of weeks, and based on one of their PRs in April, looks they should be OTCQB listed and DTC eligible imminetly. This should be ...more  
Comment by Bookworm28 on May 18, 2021 10:02pm
I hope you'r right ValueValue123 when you say the OTDQB listing, and DTC eligibility should be the turning point. I like the science, but that only goes so far when you're a mile underwater and the tide just keeps rising. I think the market maker and the IR guys have to take some responsibility for the low daily volumes and declining price. The company is in good shape, the science and ...more